本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acrivon Therapeutics, Inc.

1.75
-0.1500-7.89%
盘后:1.770.0178+1.02%19:30 EDT
成交量:47.73万
成交额:84.97万
市值:7,490.25万
市盈率:-0.93
高:1.87
开:1.86
低:1.74
收:1.90
52周最高:3.56
52周最低:1.27
股本:4,280.14万
流通股本:2,582.82万
量比:2.00
换手率:1.85%
股息:- -
股息率:- -
每股收益(TTM):-1.8800
每股收益(LYR):-2.0151
净资产收益率:-64.63%
总资产收益率:-38.02%
市净率:0.86
市盈率(LYR):-0.87

数据加载中...

2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

SEC问询函

Form CORRESP - Correspondence
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/13

SEC问询函

Form CORRESP - Correspondence
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]